
Colivib 1MIU Injection
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Colistimethate Sodium (1Million IU)
Overview Colivib 1MIU Injection
Colivib 1MIU Injection, a potent antibacterial agent, combats severe systemic bacterial infections. Primarily administered to critically ill hospitalized individuals, its use requires strict medical oversight. Self-administration is strictly prohibited; dosage and treatment length are determined by a physician based on infection severity and type. Consistent adherence to the prescribed regimen is crucial for optimal therapeutic outcomes. Potential adverse reactions may encompass gastrointestinal distress, dysarthria, lightheadedness, vertigo, pyrexia, cutaneous eruptions, and paresthesia. These typically resolve spontaneously as the body adapts. Persistent or troublesome side effects warrant immediate medical consultation. Prior to commencing treatment, disclosure of antibiotic allergies, renal or hepatic impairment is essential. Expectant and nursing mothers should seek medical counsel before use. Regular blood tests to assess renal function and drug levels may be conducted by the physician.
Uses of Colivib 1MIU Injection
Life-threatening bacterial infections
Major Benefits of Colivib 1MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Colivib 1MIU Injection:
- Slurred speech
- Upset stomach
- Dizziness
- Gastrointestinal disturbance
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Rash
- Fever
- Generalized itching
- Red spots or bumps
- Increased blood urea nitrogen
- Increased creatinine level in blood
- Decreased creatinine clearance
- Respiratory distress
- Apnea (absence of breathing)
- Renal toxicity
- Decreased urinary volume
How to use Colivib 1MIU Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Colivib 1MIU Injection works:
Colivib 1MIU, administered via injection, is a bactericidal antibiotic that disrupts bacterial cell membranes.
SAFETY ADVICE
AlcoholSAFE
Colivib 1MIU Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
The use of Colivib 1MIU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Colivib 1 MIU Injection without significant risk to their infants. Available data from human studies indicates minimal danger to the nursing child.
DrivingUNSAFE
Administration of Colivib 1 MIU Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Caution is advised when administering Colivib 1MIU Injection to individuals with impaired renal function. Dosage modification for Colivib 1MIU Injection might be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Colivib 1MIU Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Colivib 1MIU Injection :
NA
Facts to Know About Colivib 1MIU Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Type of Therapy | Anti-Infective Agents |
